Update on MDR Tuberculosis
Language: English
Published by Jaypee Brothers Medical Publishers, IN, 2024
- Softcover
- New
Seller: Rarewaves.com USA, London, London, United KingdomRarewaves.com USA
AbeBooks seller since June 11, 2025
Condition: New
£ 31.33
Quantity: 1 available
Add to basketSeller Inventory # LU-9789366162423
- Title
- Update on MDR Tuberculosis
- Author
- VK Arora, Kamal Chopra
- Publisher
- Jaypee Brothers Medical Publishers, IN
- Publication year
- 2024
- Condition
- New
- Binding
- Paperback
- Language
- English
- ISBN 10
- 9366162428
- ISBN 13
- 9789366162423
- Item weight
- 300 grams
- Dimensions
- 15.9 x 1.4 x 23.1 cm
Section 1: General
1. Impact of Higher Prevalence in Countries with Evolving Healthcare Systems and High Multidrug-resistant Tuberculosis Burden
2. How Multidrug-resistant Tuberculosis Poses a Major Challenge to Global TB Control Efforts?
3. Hotspots of Drug-resistant Tuberculosis as Key Drivers of Epidemic Intelligence for Public Health Action
4. Antibiotic Resistance Factors in Multidrug-resistant Tuberculosis
5. Trends in Multidrug-resistant Tuberculosis
6. Barriers in the Development of Specific Drug Susceptibility Testing
Section 2: Diagnostic
7. Decoding Resistance: Role of Mutations in Tuberculosis Treatment Failure
8. Early Detection Tools of Pulmonary Tuberculosis Affecting Treatment Outcome
9. How One Can Lead to Extensively Drug-resistant Tuberculosis?
10. Strain Typing Methods in the Identification of Drug Resistance in Mycobacterium Tuberculosis
11. Pattern and Characteristics of Mutation in Drug-resistant Clinical Isolates of Extrapulmonary Tuberculosis
12. Impact of Genome Sequencing on Multidrug-resistant Tuberculosis Diagnosis and Prevalence
13. Current Advances and Persistent Challenges in the Treatment of Pediatric Drug-resistant Tuberculosis
Section 3: Clinical
14. Closing the Gap between Evidence and Implementation in Multidrug-resistant Tuberculosis Management
15. Significance of Inappropriate or Interrupted Treatment in Tuberculosis
16. Nonadherence to Medication Regimens: Impact on Drug Resistance
17. Strategies to Prevent Mortality and Severe Illness in Multidrug-resistant Tuberculosis
18. Therapeutic Drugs Monitoring in Multidrug-resistant Treatment
Section 4: Treatment
19. Phytochemicals to Combat Multidrug-resistant Tuberculosis
20. Revolutionizing Drug-resistant Tuberculosis Care: The Global BPaL Implementation Experience
21. Poor Drug Quality: Impact on Drug Resistance
22. Surgical Modalities in Multidrug-resistant/Extensively Drug-resistant Tuberculosis
23. Recent Advances in Management of Drug-resistant Tuberculosis
24. Global Drug Pipeline for Tuberculosis Treatment
25. Current Regimens for Drug-resistant Tuberculosis
26. Challenges in Early Detection, Management and Prevention of Multidrug-resistant Tuberculosis in Geriatric Patients
Section 5: Associated Diseases
27. Multidrug-resistant Tuberculosis during Pregnancy
28. Molecular Changes in Diabetes and Multidrug-resistant Tuberculosis
29. Psychiatric Disorders in Drug-resistant Tuberculosis
30. Antimicrobial Resistance Fight: Preventing Drug Resistance
31. Mitigating Strategies to Prevent Drug Resistance
32. Airborne Transmission of Drug-resistant Tuberculosis
33. Problematic Issues in Implementation of Drug-resistant Tuberculosis Case Management
Section 6: Prevention
34. Multidrug Resistance in Tuberculosis: Contact Tracing and Isolation of Infected Individuals
35. Multidrug-resistant Tuberculosis: Infection Prevention and Control Measures in Healthcare Settings
36. Importance of Prevention, Early Diagnosis and Adherence to Treatment: Latent and Subclinical TB
37. Novel Tuberculosis Vaccines: A Promising Approach for Multidrug-resistant Tuberculosis Elimination
Section 7: Newer Initiatives
38. Role of Artificial Intelligence in Tuberculosis
39. Artificial Intelligence in Managing Drug Adherence
40. Role of DNA Fingerprinting in Multidrug-resistant Tuberculosis
41. Epigenetic Regulation of Drug Resistance in Tuberculosis
42. Functional Analysis of Toxin-antitoxin System in Multidrug-resistant Tuberculosis
43. Phenotypic Drug Resistance: An Update in Pediatric Tuberculosis
"Synopsis" may belong to another edition of this title.
About the Author
VK Arora Diploma in Chest Diseases (DCD) MD (Tuberculosis and Respiratory Diseases/Medicine) MBBS
Tuberculous and Chest Diseases Specialist; Chairman, TB Association of India; Executive Editor of Indian Journal of Tuberculosis, New Delhi, India
Kamal Chopra MBBS MD (Chest and TB) DTCE (Diploma in TB Control and Eradication) Tokyo
Consultant and Former Director, New Delhi Tuberculosis Centre; Academic Editor, PLoS One; Associate Executive Editor of Indian Journal of Tuberculosis, New Delhi, India
"About the title" may belong to another edition of this title.
Rarewaves.com USA
London, London, United Kingdom
AbeBooks seller since June 11, 2025
Shipping rates from United Kingdom to U.S.A.
| Item | 9 to 14 business days | 9 to 14 business days |
|---|---|---|
| First item | £ 0.00 | £ 0.00 |
Payment methods
Seller's business information
RAREWAVES.COM LIMITED
Elsley Court, 20-22 Great Titchfield Street
London, United Kingdom W1W 8BE
Right of withdrawal
If you are a consumer you can withdraw from the contract in accordance with the following. Consumer means any natural person who is acting for purposes which are outside his trade, business, craft or profession.
Information regarding the right of withdrawal
Statutory right to withdraw
You have the right to withdraw from this contract within 14 days without giving any reason.
The withdrawal period will expire after 14 days from the day on which you acquire, or a third party other than the carrier and indicated by you acquires, physical possession of the last good or the last lot or piece.
To exercise the right of withdrawal, electronically fill in and submit a clear statement on our website, under "My Purchases" in "My Account". We will communicate to you an acknowledgement of receipt of such a withdrawal on a durable medium (e.g. by e-mail) without delay.
To meet the withdrawal deadline, it is sufficient for you to send your communication concerning your exercise of the right of withdrawal before the withdrawal period has expired.
Effects of withdrawal
If you withdraw from this contract, we will reimburse to you all payments received from you, including the costs of delivery (except for the supplementary costs arising if you chose a type of delivery other than the least expensive type of standard delivery offered by us).
We may make a deduction from the reimbursement for loss in value of any goods supplied, if the loss is the result of unnecessary handling by you.
We will make the reimbursement without undue delay, and not later than 14 days after the day on which we are informed about your decision to withdraw from this contract.
We will make the reimbursement using the same means of payment as you used for the initial transaction, unless you have expressly agreed otherwise; in any event, you will not incur any fees as a result of such reimbursement.
We may withhold reimbursement until we have received the goods back, or you have supplied evidence of having sent back the goods, whichever is the earliest.
You shall send back the goods or hand them over to Rarewaves.com USA, Unit 144 The Lightbox, 111 Power Road, W4 5PY, London, London, United Kingdom, without undue delay and in any event not later than 14 days from the day on which you communicate your withdrawal from this contract to us. The deadline is met if you send back the goods before the period of 14 days has expired. You will have to bear the direct cost of returning the goods. You are only liable for any diminished value of the goods resulting from the handling other than what is necessary to establish the nature, characteristics and functioning of the goods.
Exceptions to the right of withdrawal
The right of withdrawal does not apply to:
- The delivery of newspapers, journals or magazines with the exception of subscription contracts; and
- The supply of digital content which is not supplied on a tangible medium (e.g. on a CD or DVD) if you accepted when you placed your order that we could start to deliver it, and that you could not withdraw once delivery had started.
Shipping terms
Please note that we do not offer Priority shipping to any country.
We currently do not ship to the below countries:
Russia
Belarus
Ukraine
Please do not attempt to place orders with any of these countries as a ship to address - they will be cancelled.